 | • レポートコード：MRC23Q36521 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の同種移植真皮市場について調査・分析し、世界の同種移植真皮市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（動物由来、ヒト由来）、用途別セグメント分析（病院、診療所）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、MTF Biologics、Allosource、Parametrics Medical、LifeNet Health、Gunze、Tissue Regenix、Zimmer Biomet、Integra LifeSciences、Organogenesis、Flower Orthopedics、Promethean、Wright Medical Group、Aziyo Biologics、RTI Surgical、MiMedx Group、Tides Medical、Ventris Medical、Vivex Biomedical、Aedicell、Amniox Medical、StimLabs、Skye Biologicsなどが含まれています。 世界の同種移植真皮市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、同種移植真皮市場規模を推定する際に考慮しました。本レポートは、同種移植真皮の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、同種移植真皮に関するビジネス上の意思決定に役立てることを目的としています。 ・同種移植真皮市場の概要 - 製品の定義 - 同種移植真皮のタイプ別セグメント - 世界の同種移植真皮市場規模：タイプ別分析（動物由来、ヒト由来） - 同種移植真皮の用途別セグメント - 世界の同種移植真皮市場規模：用途別分析（病院、診療所） - 世界の同種移植真皮市場規模予測（2018年-2029年） - 同種移植真皮の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 同種移植真皮市場の競争状況およびトレンド ・同種移植真皮の地域別市場規模 - 北米の同種移植真皮市場規模（2018年-2029年） - アメリカの同種移植真皮市場規模（2018年-2029年） - ヨーロッパの同種移植真皮市場規模（2018年-2029年） - アジア太平洋の同種移植真皮市場規模（2018年-2029年） - 中国の同種移植真皮市場規模（2018年-2029年） - 日本の同種移植真皮市場規模（2018年-2029年） - 韓国の同種移植真皮市場規模（2018年-2029年） - インドの同種移植真皮市場規模（2018年-2029年） - オーストラリアの同種移植真皮市場規模（2018年-2029年） - 中南米の同種移植真皮市場規模（2018年-2029年） - 中東・アフリカの同種移植真皮市場規模（2018年-2029年） ・タイプ別セグメント：動物由来、ヒト由来 - 世界の同種移植真皮のタイプ別販売量（2018年-2023年） - 世界の同種移植真皮のタイプ別売上（2018年-2023年） - 世界の同種移植真皮のタイプ別価格 ・用途別セグメント：病院、診療所 - 世界の同種移植真皮の用途別販売量（2018年-2023年） - 世界の同種移植真皮の用途別売上（2018年-2023年） - 世界の同種移植真皮の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 MTF Biologics、Allosource、Parametrics Medical、LifeNet Health、Gunze、Tissue Regenix、Zimmer Biomet、Integra LifeSciences、Organogenesis、Flower Orthopedics、Promethean、Wright Medical Group、Aziyo Biologics、RTI Surgical、MiMedx Group、Tides Medical、Ventris Medical、Vivex Biomedical、Aedicell、Amniox Medical、StimLabs、Skye Biologics ・産業チェーンと販売チャネルの分析 - 同種移植真皮産業チェーン分析 - 同種移植真皮の主要原材料 - 同種移植真皮の販売チャネル - 同種移植真皮のディストリビューター - 同種移植真皮の主要顧客 ・同種移植真皮市場ダイナミクス - 同種移植真皮の業界動向 - 同種移植真皮市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Allograft Dermis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Allograft Dermis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Allograft Dermis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Allograft Dermis include MTF Biologics, Allosource, Parametrics Medical, LifeNet Health, Gunze, Tissue Regenix, Zimmer Biomet, Integra LifeSciences and Organogenesis, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Allograft Dermis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allograft Dermis.
The Allograft Dermis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Allograft Dermis market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allograft Dermis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
MTF Biologics
Allosource
Parametrics Medical
LifeNet Health
Gunze
Tissue Regenix
Zimmer Biomet
Integra LifeSciences
Organogenesis
Flower Orthopedics
Promethean
Wright Medical Group
Aziyo Biologics
RTI Surgical
MiMedx Group
Tides Medical
Ventris Medical
Vivex Biomedical
Aedicell
Amniox Medical
StimLabs
Skye Biologics
Segment by Type
From Animal Source
From Human Source
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Allograft Dermis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Allograft Dermis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Allograft Dermis Market Overview
1.1 Product Overview and Scope of Allograft Dermis
1.2 Allograft Dermis Segment by Type
1.2.1 Global Allograft Dermis Market Value Comparison by Type (2023-2029)
1.2.2 From Animal Source
1.2.3 From Human Source
1.3 Allograft Dermis Segment by Application
1.3.1 Global Allograft Dermis Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Allograft Dermis Market Size Estimates and Forecasts
1.4.1 Global Allograft Dermis Revenue 2018-2029
1.4.2 Global Allograft Dermis Sales 2018-2029
1.4.3 Global Allograft Dermis Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Allograft Dermis Market Competition by Manufacturers
2.1 Global Allograft Dermis Sales Market Share by Manufacturers (2018-2023)
2.2 Global Allograft Dermis Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Allograft Dermis Average Price by Manufacturers (2018-2023)
2.4 Global Allograft Dermis Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Allograft Dermis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Allograft Dermis, Product Type & Application
2.7 Allograft Dermis Market Competitive Situation and Trends
2.7.1 Allograft Dermis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Allograft Dermis Players Market Share by Revenue
2.7.3 Global Allograft Dermis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Allograft Dermis Retrospective Market Scenario by Region
3.1 Global Allograft Dermis Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Allograft Dermis Global Allograft Dermis Sales by Region: 2018-2029
3.2.1 Global Allograft Dermis Sales by Region: 2018-2023
3.2.2 Global Allograft Dermis Sales by Region: 2024-2029
3.3 Global Allograft Dermis Global Allograft Dermis Revenue by Region: 2018-2029
3.3.1 Global Allograft Dermis Revenue by Region: 2018-2023
3.3.2 Global Allograft Dermis Revenue by Region: 2024-2029
3.4 North America Allograft Dermis Market Facts & Figures by Country
3.4.1 North America Allograft Dermis Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Allograft Dermis Sales by Country (2018-2029)
3.4.3 North America Allograft Dermis Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Allograft Dermis Market Facts & Figures by Country
3.5.1 Europe Allograft Dermis Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Allograft Dermis Sales by Country (2018-2029)
3.5.3 Europe Allograft Dermis Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Allograft Dermis Market Facts & Figures by Country
3.6.1 Asia Pacific Allograft Dermis Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Allograft Dermis Sales by Country (2018-2029)
3.6.3 Asia Pacific Allograft Dermis Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Allograft Dermis Market Facts & Figures by Country
3.7.1 Latin America Allograft Dermis Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Allograft Dermis Sales by Country (2018-2029)
3.7.3 Latin America Allograft Dermis Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Allograft Dermis Market Facts & Figures by Country
3.8.1 Middle East and Africa Allograft Dermis Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Allograft Dermis Sales by Country (2018-2029)
3.8.3 Middle East and Africa Allograft Dermis Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Allograft Dermis Sales by Type (2018-2029)
4.1.1 Global Allograft Dermis Sales by Type (2018-2023)
4.1.2 Global Allograft Dermis Sales by Type (2024-2029)
4.1.3 Global Allograft Dermis Sales Market Share by Type (2018-2029)
4.2 Global Allograft Dermis Revenue by Type (2018-2029)
4.2.1 Global Allograft Dermis Revenue by Type (2018-2023)
4.2.2 Global Allograft Dermis Revenue by Type (2024-2029)
4.2.3 Global Allograft Dermis Revenue Market Share by Type (2018-2029)
4.3 Global Allograft Dermis Price by Type (2018-2029)
5 Segment by Application
5.1 Global Allograft Dermis Sales by Application (2018-2029)
5.1.1 Global Allograft Dermis Sales by Application (2018-2023)
5.1.2 Global Allograft Dermis Sales by Application (2024-2029)
5.1.3 Global Allograft Dermis Sales Market Share by Application (2018-2029)
5.2 Global Allograft Dermis Revenue by Application (2018-2029)
5.2.1 Global Allograft Dermis Revenue by Application (2018-2023)
5.2.2 Global Allograft Dermis Revenue by Application (2024-2029)
5.2.3 Global Allograft Dermis Revenue Market Share by Application (2018-2029)
5.3 Global Allograft Dermis Price by Application (2018-2029)
6 Key Companies Profiled
6.1 MTF Biologics
6.1.1 MTF Biologics Corporation Information
6.1.2 MTF Biologics Description and Business Overview
6.1.3 MTF Biologics Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.1.4 MTF Biologics Allograft Dermis Product Portfolio
6.1.5 MTF Biologics Recent Developments/Updates
6.2 Allosource
6.2.1 Allosource Corporation Information
6.2.2 Allosource Description and Business Overview
6.2.3 Allosource Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Allosource Allograft Dermis Product Portfolio
6.2.5 Allosource Recent Developments/Updates
6.3 Parametrics Medical
6.3.1 Parametrics Medical Corporation Information
6.3.2 Parametrics Medical Description and Business Overview
6.3.3 Parametrics Medical Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Parametrics Medical Allograft Dermis Product Portfolio
6.3.5 Parametrics Medical Recent Developments/Updates
6.4 LifeNet Health
6.4.1 LifeNet Health Corporation Information
6.4.2 LifeNet Health Description and Business Overview
6.4.3 LifeNet Health Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LifeNet Health Allograft Dermis Product Portfolio
6.4.5 LifeNet Health Recent Developments/Updates
6.5 Gunze
6.5.1 Gunze Corporation Information
6.5.2 Gunze Description and Business Overview
6.5.3 Gunze Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Gunze Allograft Dermis Product Portfolio
6.5.5 Gunze Recent Developments/Updates
6.6 Tissue Regenix
6.6.1 Tissue Regenix Corporation Information
6.6.2 Tissue Regenix Description and Business Overview
6.6.3 Tissue Regenix Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Tissue Regenix Allograft Dermis Product Portfolio
6.6.5 Tissue Regenix Recent Developments/Updates
6.7 Zimmer Biomet
6.6.1 Zimmer Biomet Corporation Information
6.6.2 Zimmer Biomet Description and Business Overview
6.6.3 Zimmer Biomet Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zimmer Biomet Allograft Dermis Product Portfolio
6.7.5 Zimmer Biomet Recent Developments/Updates
6.8 Integra LifeSciences
6.8.1 Integra LifeSciences Corporation Information
6.8.2 Integra LifeSciences Description and Business Overview
6.8.3 Integra LifeSciences Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Integra LifeSciences Allograft Dermis Product Portfolio
6.8.5 Integra LifeSciences Recent Developments/Updates
6.9 Organogenesis
6.9.1 Organogenesis Corporation Information
6.9.2 Organogenesis Description and Business Overview
6.9.3 Organogenesis Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Organogenesis Allograft Dermis Product Portfolio
6.9.5 Organogenesis Recent Developments/Updates
6.10 Flower Orthopedics
6.10.1 Flower Orthopedics Corporation Information
6.10.2 Flower Orthopedics Description and Business Overview
6.10.3 Flower Orthopedics Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Flower Orthopedics Allograft Dermis Product Portfolio
6.10.5 Flower Orthopedics Recent Developments/Updates
6.11 Promethean
6.11.1 Promethean Corporation Information
6.11.2 Promethean Allograft Dermis Description and Business Overview
6.11.3 Promethean Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Promethean Allograft Dermis Product Portfolio
6.11.5 Promethean Recent Developments/Updates
6.12 Wright Medical Group
6.12.1 Wright Medical Group Corporation Information
6.12.2 Wright Medical Group Allograft Dermis Description and Business Overview
6.12.3 Wright Medical Group Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Wright Medical Group Allograft Dermis Product Portfolio
6.12.5 Wright Medical Group Recent Developments/Updates
6.13 Aziyo Biologics
6.13.1 Aziyo Biologics Corporation Information
6.13.2 Aziyo Biologics Allograft Dermis Description and Business Overview
6.13.3 Aziyo Biologics Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Aziyo Biologics Allograft Dermis Product Portfolio
6.13.5 Aziyo Biologics Recent Developments/Updates
6.14 RTI Surgical
6.14.1 RTI Surgical Corporation Information
6.14.2 RTI Surgical Allograft Dermis Description and Business Overview
6.14.3 RTI Surgical Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.14.4 RTI Surgical Allograft Dermis Product Portfolio
6.14.5 RTI Surgical Recent Developments/Updates
6.15 MiMedx Group
6.15.1 MiMedx Group Corporation Information
6.15.2 MiMedx Group Allograft Dermis Description and Business Overview
6.15.3 MiMedx Group Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.15.4 MiMedx Group Allograft Dermis Product Portfolio
6.15.5 MiMedx Group Recent Developments/Updates
6.16 Tides Medical
6.16.1 Tides Medical Corporation Information
6.16.2 Tides Medical Allograft Dermis Description and Business Overview
6.16.3 Tides Medical Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Tides Medical Allograft Dermis Product Portfolio
6.16.5 Tides Medical Recent Developments/Updates
6.17 Ventris Medical
6.17.1 Ventris Medical Corporation Information
6.17.2 Ventris Medical Allograft Dermis Description and Business Overview
6.17.3 Ventris Medical Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Ventris Medical Allograft Dermis Product Portfolio
6.17.5 Ventris Medical Recent Developments/Updates
6.18 Vivex Biomedical
6.18.1 Vivex Biomedical Corporation Information
6.18.2 Vivex Biomedical Allograft Dermis Description and Business Overview
6.18.3 Vivex Biomedical Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Vivex Biomedical Allograft Dermis Product Portfolio
6.18.5 Vivex Biomedical Recent Developments/Updates
6.19 Aedicell
6.19.1 Aedicell Corporation Information
6.19.2 Aedicell Allograft Dermis Description and Business Overview
6.19.3 Aedicell Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Aedicell Allograft Dermis Product Portfolio
6.19.5 Aedicell Recent Developments/Updates
6.20 Amniox Medical
6.20.1 Amniox Medical Corporation Information
6.20.2 Amniox Medical Allograft Dermis Description and Business Overview
6.20.3 Amniox Medical Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Amniox Medical Allograft Dermis Product Portfolio
6.20.5 Amniox Medical Recent Developments/Updates
6.21 StimLabs
6.21.1 StimLabs Corporation Information
6.21.2 StimLabs Allograft Dermis Description and Business Overview
6.21.3 StimLabs Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.21.4 StimLabs Allograft Dermis Product Portfolio
6.21.5 StimLabs Recent Developments/Updates
6.22 Skye Biologics
6.22.1 Skye Biologics Corporation Information
6.22.2 Skye Biologics Allograft Dermis Description and Business Overview
6.22.3 Skye Biologics Allograft Dermis Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Skye Biologics Allograft Dermis Product Portfolio
6.22.5 Skye Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Allograft Dermis Industry Chain Analysis
7.2 Allograft Dermis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Allograft Dermis Production Mode & Process
7.4 Allograft Dermis Sales and Marketing
7.4.1 Allograft Dermis Sales Channels
7.4.2 Allograft Dermis Distributors
7.5 Allograft Dermis Customers
8 Allograft Dermis Market Dynamics
8.1 Allograft Dermis Industry Trends
8.2 Allograft Dermis Market Drivers
8.3 Allograft Dermis Market Challenges
8.4 Allograft Dermis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer